Yao Guangzhe, Miao Xinxin, Wu Mengxuan, Lv Zhenguo, Bai Yu, Chang Yanxu, Ouyang Huizi, He Jun
Tianjin State Key Laboratory of Component-based Chinese Medicine, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Haihe Laboratory of Modern Chinese Medicine, Tianjin, China.
Front Pharmacol. 2023 Jan 13;14:1067089. doi: 10.3389/fphar.2023.1067089. eCollection 2023.
Retz. (TC) is a well-known Chinese herbal medicine and rich in chemical components with multiple pharmacological effects. In this study, an ultra-performance liquid chromatography-tandem mass spectroscopy (UPLC-MS/MS) method was developed and used to determine the blood concentrations of nine active compounds (chebulic acid, gallic acid, protocatechuic acid, corilagin, chebulagic acid, chebulinic acid, 1,2,3,4,6-O-pentagalloylglucose, ellagic acid and ethyl gallate) after oral administration of TC extracts in rats. Pretreatment of plasma samples with protein precipitate with methanol was carried out, and caffeic acid was used as the internal standard (IS). Compounds precisions of intra- and inter-day were less than 14.6%, and the accuracy ranged from -11.7% to 13.5%. The extraction recoveries of compounds were between 84.9% and 108.4%, while matrix effects occurred between 86.4% and 115.9%. Stability tests showed that all nine analytes had been stable under four storage conditions, and statistically significant the relative standard deviations were under 13.7%. The validated UPLC-MS/MS method was applied with great success to plasma pharmacokinetics analysis of the TC extracts, and the pharmacokinetic results showed that among the nine components, the area under the concentration-time curve (AUC, 231112.38 ± 64555.20 h ng/mL) and maximum concentration (C, 4,983.57 ± 1721.53 ng/mL) of chebulagic acid were relatively large, which indicated that it had a higher level of plasma exposure. The half-life of elimination (T) of chebulinic acid, corilagin and chebulagic acid were 43.30, 26.39 and 19.98 h, respectively, suggesting that these analytes showed prolonged retention and metabolize more slowly . This study would deliver a theoretical foundation for the further application of TC in clinical practice.
诃子(TC)是一种著名的中草药,富含具有多种药理作用的化学成分。在本研究中,开发了一种超高效液相色谱 - 串联质谱(UPLC - MS/MS)方法,并用于测定大鼠口服TC提取物后九种活性化合物(诃子酸、没食子酸、原儿茶酸、柯里拉京、诃子次酸、诃子林酸、1,2,3,4,6 - O - 五没食子酰葡萄糖、鞣花酸和没食子酸乙酯)的血药浓度。采用甲醇蛋白沉淀法对血浆样品进行预处理,以咖啡酸作为内标(IS)。化合物日内和日间精密度均小于14.6%,准确度范围为 - 11.7%至13.5%。化合物的提取回收率在84.9%至108.4%之间,基质效应在86.4%至115.9%之间。稳定性试验表明,所有九种分析物在四种储存条件下均稳定,相对标准偏差在统计学上显著低于13.7%。经过验证的UPLC - MS/MS方法成功应用于TC提取物的血浆药代动力学分析,药代动力学结果表明,在这九种成分中,诃子次酸的浓度 - 时间曲线下面积(AUC,231112.38 ± 64555.20 h ng/mL)和最大浓度(C,4983.57 ± 1721.53 ng/mL)相对较大,这表明其血浆暴露水平较高。诃子林酸、柯里拉京和诃子次酸的消除半衰期(T)分别为43.30、26.39和19.98 h,表明这些分析物显示出较长的滞留时间且代谢较慢。本研究将为TC在临床实践中的进一步应用提供理论基础。